Teva and Sanofi’s IBD Drug Achieves Primary Targets in Phase 2 Study
Israel’s Teva Pharmaceutical Industries and French drugmaker Sanofi announced that their jointly developed drug for treating ulcerative colitis and Crohn’s disease has successfully met its primary...